Eisai, Pfizer deal

Pfizer disclosed in its 1Q09 earnings that it received a letter from Eisai stating that upon the closing of Pfizer's acquisition of Wyeth (NYSE:WYE, Madison, N.J.), Eisai will have the right to termi...